Encefalomielitis aguda diseminada. Leucoencefalitis aguda hemorrágica. Otras enfermedades desmielinizantes

  1. Delgado, F. Romero
  2. Monteiro, G. Carvalho
  3. Margarit, B. Povedano
  4. Izquierdo, A. Yusta
Zeitschrift:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Datum der Publikation: 2019

Titel der Ausgabe: Enfermedades del sistema nervioso (IX)Enfermedades desmielinizantes del sistema nervioso central

Serie: 12

Nummer: 78

Seiten: 4606-4615

Art: Artikel

DOI: 10.1016/J.MED.2019.05.012 DIALNET GOOGLE SCHOLAR

Andere Publikationen in: Medicine: Programa de Formación Médica Continuada Acreditado

Zusammenfassung

Resumen Existen enfermedades desmielinizantes del sistema nervioso central distintas a la esclerosis múltiple. Los criterios diagnósticos permiten ayudar a realizar un diagnóstico precoz de las distintas enfermedades; sin embargo, el diagnóstico diferencial es amplio. Por ello es necesario conocer las características atípicas (banderas rojas) de cada enfermedad para poder realizar un diagnóstico correcto y ofrecer las medidas terapéuticas oportunas. Los avances en neuroimagen y en las técnicas de laboratorio están ayudando a caracterizar y diferenciar los distintos tipos de enfermedades. En la presente actualización se revisarán los aspectos más importantes de cada una de ellas. There are demyelinating diseases of the central nervous system other than multiple sclerosis. The diagnostic criteria help to reach an early diagnosis of the various diseases; however, the differential diagnosis is broad. We therefore need to understand the atypical characteristics (red flags) of each disease to perform a correct diagnosis and offer appropriate therapeutic measures. The advances in neuroimaging and laboratory techniques are helping characterize and differentiate the various types of diseases. In this update, we review the most important aspects of each disease.

Bibliographische Referenzen

  • Alves-leon SV, Veluttini-Pimentel ML, Gouveia ME, Gaspareto EL, Alvarenga MP, Frugulhetti I. Acute disseminated encephalomyelitis. Arq Neuropsiquiatr. 2009;67:643-51.
  • Balo J. Encephalitis periaxialis concentrica. Arch Neurol Psychiatry. 1928 Feb 1;19(2):242.
  • Baumann M, Sahin K, Lechner C, Hennes EM, Schanda K, Mader S. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oli-godendrocyte glycoprotein. J Neurol Neurosurg Psychiatry. 2014;265-72.
  • Bennett JL, Cabre P, Carroll W, Jacob A, Jarius S, Lanapeixoto M. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177-89.
  • Bevan CJ, Cree BA. Fulminant demyelinating diseases of the central nervous system. Semin Neurol. 2015;35(6):656-66.
  • Burns KH, Pardo SJ, Sobreira NL, Mealy MA, Valle D, Pardo CA. Familial monophasic acute transverse myelitis due to the pathogenic variant in VPS37A . Neurol Genet. 2018;4(1):e213.
  • Cañellas AR, Gols AR, Izquierdo JR, Subirana MT, Gairin XM. Idiopathic inflammatory demyelinating diseases of the central nervous sys-tem. Neuroradiology [Internet]. 2007;49(5):393-409.
  • Charil A, Yousry TA, Rovaris M, Barkhof F, Stefano N De, Faze-kas F. Review MRI and the diagnosis of multiple sclerosis : expanding the concept of “no better explanation”. Lancet Neurol. 2006;(5):841-52.
  • Cree BAC. Acute inflammatory myelopathies. Handbook of clinical neurology. 1st ed. Amsterdam: Else-vier B.V.; 2014. p. 613-67.
  • Elenein RGA, Sharer LR, Cook SD, Pachner AR, Michaels J, Hillen ME. A second case of Marburg’s variant of multiple sclerosis with vasculitis and extensive demyelination. Mult Scler J. 2011;17(12):1531-8.
  • García Domínguez JM, Guzmán de Villoria Lebiedziejewski J. Catástrofes neurológicas por enfermedades desmielinizantes. Neurologia. 2010;25Suppl1:30-6.
  • Hardy TA, Miller DH. Baló’s concentric sclerosis. Lancet Neurol [Inter-net]. 2014;13(7):740-6.
  • Hart MN, Earle KM. Haemorrhagic clinical-pathological encephalitis: a clinical pathological review of 38 cases. J Neurol Neurosurg Psychiatry. 1975;(1972):585-91
  • Höftberger R, Lassmann H. Inflammatory demyelinating diseases of the central nervous system. Handbook of cli-nical neurology. 2018. p. 263-83.
  • Jarius S, Paul F, Aktas O, Asgari N, Dale RC, De Seze J. MOG encephalomyelitis : international recommendations on diagnosis and antibody testing. J Neuroinflammation. 2018;15(134):1-10.
  • Kidd D, Burton B, Plant GT, Graham EM. Chronic relapsing inflammatory optic neuropathy (CRION). Brain. 2003;126(2):276-84.
  • Korte JH, Bom EP, Vos LD, Breuer TJM, Wondergem JHM. Balo concentric sclerosis: MR diagnosis. Am J Neuroradiol. 1994;15(7):1284-5.
  • Krupp LB, Tardieu M, Amato MP, Chitnis T, Dale RC, Ghezzi A. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune mediated central nervous system demyelinating disorders : revisions to the 2007 definitions. Mult Scler J. 2013;19(10):1261-7.
  • Lee HJ, Kim B, Waters P, Woodhall M, Irani S, Ahn S. Chronic relapsing inflammatory optic neuropathy (CRION): A manifestation of myelin oligodendrocyte glycoprotein antibodies. J Neuroinflammation. 2018;15(1):1.
  • Mariano R, Flanagan EP, Weinshenker BG, Palace J. A practical approach to the diagnosis of spinal cord lesions. Pract Neurol. 2018;18(3):187-200.
  • Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler. 2008;14(9):1157-74.
  • Misu T, Sato DK, Nakashima I, Fujihara K. MOG-IgG serological status matters in paediatric ADEM. J Neurol Neurosurg Psychiatry. 2014;86(3):2015.
  • Narula S, Banwell B. Pediatric demyelination. Contin Lifelong Learn Neurol. 2016;22:897-915.
  • Palace J, Leite I, Jacob A. A practical guide to the treatment of neuromyelitis optica. Pract Neurol. 2012;12(4):209-14.
  • Palace J. Acute disseminated encephalomyelitis and its place amongst other acute inflammatory demyelinating CNS disorders. J Neurol Sci. 2011;306(1-2):188-91.
  • Petzold A, Plant GT. Chronic relapsing inflammatory optic neuropathy: A systematic review of 122 cases reported. J Neurol. 2014;261(1):17-26.
  • Pittock SJ, Lucchinetti CF. Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later. Ann N Y Acad Sci. 2016;1366(1):20-39.
  • Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol [Internet]. 2011;69(2):292-302.
  • Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol. 2019;15(2):89-102.
  • Rolak LA, Fleming JO. The differential diagnosis of multiple sclerosis. Neurologist [Internet]. 2007;13(2):57-72.
  • Romero Delgado F, Cuello JP, García Domínguez JM, Higueras Hernández Y, Goicochea-Briceño H, Guzmán de Villoria JA. Neuromyelitis optica spectrum disorder in a ninety year old woman. A Case Report. Int J Neurol Neurother. 2016;3(2):3-5.
  • Sand IK. Neuromyelitis optica spectrum disorders. Contin Lifelong Learn Neurol. 2016;22:864-96.
  • Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol. 2010;17(8):1019-32.
  • Simon JH, Kleinschmidt-DeMasters BK. Variants of multiple sclerosis. Neuroimaging Clin N Am [Internet]. 2008;18(4):703-16.
  • Tavasoli AR. Two cases of Schilder and Balo diseases. Iran J Child Neurol Spring. 2017;11(2):69-77.
  • Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet. Neurol. 2018;17:162-73.
  • Tinker AV, Carruthers RL, Beauchemin P, Iorio R, Field T, Traboulsee AL. Paraneoplastic neuromyelitis optica spectrum disorder: a single center cohort description with two cases of histological validation. Mult Scler Relat Disord. 2017;20:37-42.
  • Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T. Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol. 2014;75(3):411-28.
  • Wender M. Acute disseminated encephalomyelitis (ADEM). J Neuroimmunol [Internet]. 2011;231(1–2):92-9
  • Wingerchuk BDM. Immune mediated myelopathies. Continuum (Minneap Minn). 2018;24:497-522.
Fuente de los datos: Dialnet